<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: Type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> is characterised by heightened <z:mp ids='MP_0001845'>inflammation</z:mp> and <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Moderate alcohol intake has been associated with a reduced risk of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> in type 2 diabetic patients </plain></SENT>
<SENT sid="2" pm="."><plain>It remains to be determined whether there is an association between alcohol and <z:mp ids='MP_0001845'>inflammation</z:mp> in individuals with <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We investigated the relationship between alcohol intake and <z:mp ids='MP_0001845'>inflammation</z:mp> in 726 of 18,159 men who returned blood samples in the Health Professionals Follow-up Study and had confirmed type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> at blood draw </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: In age-adjusted analyses, alcohol intake was associated with lower levels of HbA1c, fibrinogen, soluble <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor receptor-2 (sTNF-R2) and soluble vascular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule-1 (sVCAM-1), and with higher levels of <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> and adiponectin (p value for trends &lt;0.05) </plain></SENT>
<SENT sid="5" pm="."><plain>After adjustment for age, HbA1c, insulin use, fasting status, smoking, BMI, physical activity, aspirin use, prevalence of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> and dietary factors, each additional drink per day was related to increased <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> (0.053 mmol/l, p&lt;0.0001) and adiponectin (0.8 microg/ml, p=0.01), and decreased sTNFR-2 (73 pg/ml, p=0.03), fibrinogen (0.302 micromol/l, p=0.02) and sVCAM-1 (33 ng/ml, p=0.02) </plain></SENT>
<SENT sid="6" pm="."><plain>The relationship between alcohol and inflammatory biomarkers persisted when subjects were stratified according to HbA1c levels </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS/INTERPRETATION: Moderate alcohol intake may have a beneficial effect on markers of <z:mp ids='MP_0001845'>inflammation</z:mp> and <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> in type 2 diabetic patients </plain></SENT>
</text></document>